Skip to main content
. 2011 Dec;85(23):12343–12350. doi: 10.1128/JVI.05682-11

Fig. 2.

Fig. 2.

Gating strategy to identify the location of p-ERK1/2-refractory cells in CD38, HLA-DR, and Tim-3+ CD8+ T cell subsets. (A) CD38+ and CD38− gates in the CD8+ T cell compartment. p-ERK1/2-refractory cells are located predominantly within the CD38+ subset. (B) HLA-DR+ and HLA-DR− gates in the CD8+ T cell compartment. p-ERK1/2-refractory cells are located predominantly within the HLA-DR+ subset. (C) TIM3+ and TIM3− gates in the CD8+ T cell compartment. p-ERK1/2-refractory cells are located predominantly in the TIM3− subset. Data are from one HIV− patient and one HIV+ patient.